Seattle, Washington
United States
40
2021-01-28
The entities that hold a legal rights for patent applications filed by inventor Senter Peter D.:
Peter D. Senter from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:
PSMA ANTIBODY-DRUG CONJUGATES
#2 | 2020-11-05MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#3 | 2019-11-07Monomethylvaline compounds capable of conjugation to ligands
#4 | 2018-05-10Monomethylvaline compounds capable of conjugation to ligands
#5 | 2017-01-05MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#6 | 2015-02-12Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus
#7 | 2014-08-07MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#8 | 2012-06-14MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#9 | 2012-06-14MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#10 | 2012-06-07MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#11 | 2012-06-07MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#12 | 2012-06-07MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#13 | 2012-02-09MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#14 | 2012-02-09MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#15 | 2012-02-02MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#16 | 2012-02-02MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#17 | 2012-01-05Monomethylvaline compounds capable of conjugation to ligands
#18 | 2012-01-05Monomethylvaline compounds capable of conjugation to ligands
#19 | 2011-11-17TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES
#20 | 2011-03-17Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
#21 | 2010-03-11Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
#22 | 2009-12-31Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
#23 | 2009-06-30-amidobenzylethers in drug delivery agents
#24 | 2009-04-30Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
#25 | 2009-02-19Monomethylvaline compounds capable of conjugation to ligands
#26 | 2008-12-25RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF
#27 | 2008-10-09Monomethylvaline compounds capable of conjugation to ligands
#28 | 2008-10-09Monomethylvaline compounds capable of conjugation to ligands
#29 | 2008-09-18Monomethylvaline compounds capable of conjugation to ligands
#30 | 2008-09-04RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF
#31 | 2007-11-08Recombinant Anti-Cd30 Antibodies and Uses Thereof
#32 | 2007-08-14Pentapeptide compounds and uses related thereto
#33 | 2007-07-12PSMA antibody-drug conjugates
#34 | 2006-10-12Pentapeptide compounds and uses related thereto
#35 | 2006-08-15-Amidobenzylethers in drug delivery agents
#36 | 2006-04-06Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
#37 | 2005-10-27Monomethylvaline compounds capable of conjugation to ligands
#38 | 2005-08-18Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disorders
#39 | 2005-05-26Pentapeptide compounds and uses related thereto
#40 | 2005-01-13Pentapeptide compounds and uses related thereto
862323 ⎘